KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
16,260
-270 (-1.63%)
Feb 21, 2025, 9:00 AM KST
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 177.34 billion as of February 21, 2025. Its market cap has decreased by -24.20% in one year.
Market Cap
177.34B
Enterprise Value
161.43B
Revenue
79.80B
Ranking
n/a
PE Ratio
59.04
Stock Price
16,260.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 177.34B, a decrease of -3.50%. That is a compound annual growth rate of -0.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 21, 2025 | 177.34B | 6.21% |
Dec 30, 2024 | 166.98B | -35.26% |
Dec 28, 2023 | 257.94B | 10.51% |
Dec 29, 2022 | 233.40B | -55.92% |
Dec 30, 2021 | 529.52B | 118.69% |
Dec 30, 2020 | 242.13B | 31.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 384.51T |
SK hynix | 144.35T |
LG Energy Solution | 88.57T |
Samsung Biologics | 82.35T |
Hyundai Motor Company | 45.50T |
Celltrion | 37.80T |
Kia Corporation | 36.86T |
NAVER | 34.26T |